About us
Navigation überspringen
Home
NTCAF ELISA
About us
Management
Board of Directors
Scientific Advisory Team
Therapeutic Areas
Pipeline
Investors
Careers
News
Events
Contact
Management
Dr. Armin W. Mäder,
Chief Executive Officer / Chief Financial Officer
Dr. Bruno Oesch,
Head BD & L
Dr. Jan Willem Vrijbloed,
Chief Scientific Officer
Prof. Ruggero Fariello,
Chief Medical Officer
Dr. Carlo Farina,
Head of Chemistry